跳至主要内容
临床试验/DRKS00015119
DRKS00015119尚未招募4 期

Pilot study to evaluate glycemic control with GlucoTab using an ultra-long acting insulin analogue in non-critically ill patients with type 2 diabetes at the general ward - Glucotab_Degludec

niv.-Klinik für Innere MedizinKlinische Abteilung für Endokrinologie und Diabetologie0 个研究点目标入组 30 人开始时间: 2019年4月29日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Informed consent obtained after being advised of the nature of the study
  • Male or female aged =18 years
  • Type 2 diabetes (treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four) or newly diagnosed hyperglycemia which requires s.c. insulin therapy

排除标准

  • Type 1 diabetes, gestational diabetes
  • Any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient
  • continuous subcutaneous insulin infusion (CSII)
  • hyperglycaemic episodes (ketoacidosis, hyperosmolar state) if they require intravenous insulin therapy
  • Any mental condition rendering the patient incapable of giving his consent
  • Known or suspected allergy to insulin degludec or insulin aspart
  • Continuous parenteral nutrition
  • Participation in another trial which can influence outcome of the trial

研究者

发起方
niv.-Klinik für Innere MedizinKlinische Abteilung für Endokrinologie und Diabetologie

相似试验